1.8700
08-1月-25 15:45:00
15 分の遅延
株式
-0.1300
-6.50%
本日の幅
1.8100 - 2.1400
ISIN
N/A
ソース
NASDAQ
Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
30 10 2023 06:30:00 提供 Nasdaq GlobeNewswire
Reviva Announces Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia
25 9 2023 05:00:00 提供 Nasdaq GlobeNewswire
Reviva to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
07 9 2023 05:00:00 提供 Nasdaq GlobeNewswire